Ignite Creation Date:
2025-12-24 @ 10:59 PM
Ignite Modification Date:
2025-12-25 @ 8:28 PM
Study NCT ID:
NCT01679769
Status:
COMPLETED
Last Update Posted:
2015-11-06
First Post:
2012-09-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis B
Sponsor:
Peking University First Hospital
Organization:
Study Overview
Official Title:
Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic
Status:
COMPLETED
Status Verified Date:
2015-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of our study is to evaluate liver fibrosis using biochemical markers, FibroScan, and radiology methods in patients with chronic hepatitis B in mainland China.
Detailed Description:
Up to Nov, 2015, total of 818 patients with chronic HBV infection had been enrolled in the study. Paired blood and liver biopsy specimen had been collected. The serum samples stored at -80 degree Celsius. All the liver biopsy samples were judged by three pathology experts, according to Ishak standard.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 81170386 | OTHER_GRANT | from The National Natural Science Foundation of China | View |